Star Bio Pharma has announced its transition to Star Bio Pharma Global Pvt. Ltd., signalling a new phase of growth focused on international markets and innovation-led expansion. The rebranding reflects the company’s ambition to strengthen its global footprint while reinforcing India’s position as a leading pharmaceutical manufacturing and export hub. Through its renewed identity, Star Bio Pharma Global Pvt. Ltd. aims to deliver high-quality, affordable pharmaceutical solutions that meet evolving international standards and support reliable healthcare supply chains worldwide.
The company emphasises that the change is more than a cosmetic shift in corporate identity. It aligns with a strategic vision to enhance manufacturing capabilities, foster global collaborations and drive research-led development across key therapeutic areas. As India’s pharmaceutical sector continues to gain prominence globally, Star Bio Pharma Global Pvt. Ltd. intends to contribute to this momentum by promoting world-class quality assurance, robust regulatory compliance and continuous innovation, thereby strengthening India’s reputation as a trusted global pharmaceutical partner.
Commenting on the transition, Ms. Pooja Ravindra Rokade, Director, Star Bio Pharma Global Pvt. Ltd., said: “Our transition to Star Bio Pharma Global Pvt. Ltd. reflects the direction in which we are growing as an organization. While our core values of quality, integrity, and patient-centricity remain unchanged, this new identity represents our ambition to serve global healthcare markets with greater scale and responsibility. We believe Indian pharmaceutical companies have a significant role to play in making quality healthcare more accessible worldwide, and we are committed to contributing to that vision through innovation, regulatory excellence, and long-term partnerships.”
Highlighting the broader significance of the milestone, Mr. Pramod Chandra, Director, Star Bio Pharma Global Pvt. Ltd., added: “This milestone is about expanding our business and strengthening India’s position as a trusted global pharmaceutical manufacturing destination. As the world increasingly looks towards India for dependable pharmaceutical solutions, we see ourselves contributing to the nation’s vision of becoming a global healthcare leader. Our focus will remain on building internationally compliant manufacturing capabilities, embracing advanced technologies, and creating sustainable value for healthcare partners and communities across the world.”
Over the years, the company has steadily expanded its manufacturing base with a strong emphasis on quality assurance, regulatory alignment and process innovation. The transition to Star Bio Pharma Global Pvt. Ltd. marks the beginning of a new chapter centred on international market expansion, advanced manufacturing practices, strategic partnerships and research-driven pharmaceutical development. By aligning its growth plans with national initiatives such as “Make in India” and India’s increasing role in global pharmaceutical exports, the company aims to generate skilled employment, support innovation and further enhance the country’s status as a reliable contributor to global healthcare.
